BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11812276)

  • 1. Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats.
    Weijtens M; van Spronsen A; Hagenbeek A; Braakman E; Martens A
    Hum Gene Ther; 2002 Jan; 13(2):187-98. PubMed ID: 11812276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of developing graft-versus-host disease mediated by herpes simplex virus thymidine kinase gene-transduced T cells.
    Kolen S; Weijtens M; Hagenbeek A; van Spronsen A; Smulders S; de Weger R; de Witte T; Dolstra H; van de Wiel van Kemenade E; Martens A
    Hum Gene Ther; 2003 Mar; 14(4):341-51. PubMed ID: 12659675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.
    Weijtens M; van Spronsen A; Hagenbeek A; de Weger R; Martens A
    Exp Hematol; 2004 Oct; 32(10):962-9. PubMed ID: 15504552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation.
    Bordignon C; Bonini C; Verzeletti S; Nobili N; Maggioni D; Traversari C; Giavazzi R; Servida P; Zappone E; Benazzi E
    Hum Gene Ther; 1995 Jun; 6(6):813-9. PubMed ID: 7548281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preemptive control of graft-versus-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
    Kornblau SM; Stiouf I; Snell V; Przepiorka D; Stephens LC; Champlin R; Marini FC
    Cancer Res; 2001 Apr; 61(8):3355-60. PubMed ID: 11309292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of graft-versus-host disease. Use of a T cell-controlled suicide gene.
    Helene M; Lake-Bullock V; Bryson JS; Jennings CD; Kaplan AM
    J Immunol; 1997 Jun; 158(11):5079-82. PubMed ID: 9164920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.
    Rettig MP; Ritchey JK; Prior JL; Haug JS; Piwnica-Worms D; DiPersio JF
    J Immunol; 2004 Sep; 173(6):3620-30. PubMed ID: 15356106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.
    Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X
    Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting.
    Contassot E; Ferrand C; Angonin R; Cohen JL; de Carvalho Bittencourt M; Lorchel F; Laithier V; Cahn JY; Klatzmann D; Herve P; Tiberghien P
    Transplantation; 2000 Feb; 69(4):503-8. PubMed ID: 10708102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study of the inhibiting effect of the lentiviral vector mediated herpes simplex virus-thymidine kinase/ganciclovir on GVHD].
    Xu KL; Zhu F; Du B; Gao F; Cheng H; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):303-7. PubMed ID: 17877157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell transduction and suicide with an enhanced mutant thymidine kinase.
    Qasim W; Thrasher AJ; Buddle J; Kinnon C; Black ME; Gaspar HB
    Gene Ther; 2002 Jun; 9(12):824-7. PubMed ID: 12040465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?
    Tiberghien P; Reynolds CW; Keller J; Spence S; Deschaseaux M; Certoux JM; Contassot E; Murphy WJ; Lyons R; Chiang Y
    Blood; 1994 Aug; 84(4):1333-41. PubMed ID: 8049449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrovirus mediated gene transduction of human T-cell subsets.
    Hedfors IA; Beckstrøm KJ; Benati C; Bonini C; Brinchmann JE
    Cancer Immunol Immunother; 2005 Aug; 54(8):759-68. PubMed ID: 15655695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human HLA-specific T-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host- graft-versus-leukemia reaction?
    Gallot G; Hallet MM; Gaschet J; Moreau JF; Vivien R; Bonneville M; Milpied N; Vié H
    Blood; 1996 Aug; 88(3):1098-103. PubMed ID: 8704220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: an altered immune response?
    Mercier-Letondal P; Deschamps M; Sauce D; Certoux JM; Milpied N; Lioure B; Cahn JY; Deconinck E; Ferrand C; Tiberghien P; Robinet E
    Hum Gene Ther; 2008 Sep; 19(9):937-50. PubMed ID: 18810797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
    Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC
    Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological defects after suicide gene therapy of experimental graft-versus-host disease.
    Cohen JL; Lacroix-Desmazes S; Charlotte F; Lejeune L; Martin PJ; Klatzmann D; Boyer O
    Hum Gene Ther; 1999 Nov; 10(16):2701-7. PubMed ID: 10566898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and culture of HSVtk transduced suicidal lymphocytes induces variable changes in the lymphocyte subset composition.
    Marini FC; Kornblau SM
    Bone Marrow Transplant; 1999 May; 23(9):907-15. PubMed ID: 10338046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.